Evaluation of the R2-ISS in Real-world Patients with Newly Diagnosed Multiple Myeloma: A Nationwide Cohort Study by the Korean Multiple Myeloma Working Party (KMM 2202)
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Kastritis E, Terpos E, Roussou M, Gavriatopoulou M, Migkou M, Eleutherakis-Papaiakovou E
. Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma. Haematologica. 2016; 102(3):593-599.
PMC: 5394955.
DOI: 10.3324/haematol.2016.145078.
View
2.
Cho H, Yoon D, Lee J, Kim S, Moon J, Do Y
. Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy. Am J Hematol. 2017; 92(12):1280-1286.
DOI: 10.1002/ajh.24891.
View
3.
DAgostino M, Cairns D, Lahuerta J, Wester R, Bertsch U, Waage A
. Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project. J Clin Oncol. 2022; 40(29):3406-3418.
DOI: 10.1200/JCO.21.02614.
View
4.
Harrell Jr F, Lee K, Califf R, Pryor D, Rosati R
. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984; 3(2):143-52.
DOI: 10.1002/sim.4780030207.
View